Corticosteroids were the mainstay of therapy for idiopathic pulmonary fibrosis (IPF) for more
than four decades, but their efficacy is unproven and toxicities are substantial. The course of …

Why are corticosteroids used in patients with IPF? There is evidence that corticosteroid
therapy is associated with clinical improvement in only a small percentage of IPF patients …

Study objectives Treatment of patients with idiopathic pulmonary fibrosis (IPF)
conventionally includes corticosteroids and cytotoxic agents. No study to date has …

Idiopathic pulmonary fibrosis (IPF), also known as cryptogenic fibrosing alveolitis, is a
distinct form of interstitial lung disease of unknown etiology that is limited to the lung; it is …

Idiopathic pulmonary fibrosis (IPF) is a highly lethal disorder associated with an extremely
poor prognosis and poor survival in most patients. Higher mortality rates attributable to …

Idiopathic pulmonary fibrosis (IPF) is a chronic condition of unknown etiology with an
unfavorable outcome from progressively deteriorating respiratory function, leading ultimately …

Idiopathic pulmonary fibrosis (IPF) is a progressive pulmonary disease leading to death
within a few years of diagnosis despite medical therapy. On the basis of methodologies of …

Purpose Idiopathic pulmonary fibrosis (IPF) has not been shown to respond to corticosteroid
therapy; however, many patients receive these drugs at the time of diagnosis. The factors …

PURPOSE: We evaluated the risk and potential benefit of high-dose corticosteroid therapy in
patients with idiopathic pulmonary fibrosis. SUBJECTS AND METHODS: We prospectively …

STUDY OBJECTIVE: To compare the survival of patients with IPF treated retrospectively with
corticosteroids alone, to survival of patients treated with immunosuppressive and …